Elucidating Neuronal and Vascular Injury Through the Cytoprotective Agent Nicotinamide
Journal:
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume:
1
Page:
257-267
Author(s):
Kenneth Maiese, Shi-Hua Lin and Zhao Zhong Chong
Pharmacologic Therapy In Traumatic Brain Injury: Update On Experimental Treatment Strategies
Journal:
Current Pharmaceutical Design
Volume:
7
Page:
1505-1516
Author(s):
H. L. Laurer and T. K. McIntosh
Therapeutic Moderate Hypothermia and Fever
Journal:
Current Pharmaceutical Design
Volume:
7
Page:
1533-1536
Author(s):
D. W. Marion
Agents for the Treatment of Glycosphingolipid Storage Disorders
Journal:
Current Drug Metabolism
Volume:
2
Page:
331-338
Author(s):
A. Abe, S. R. Wild, L. Lee and J. A. Shayman
NMDA Receptor Pharmacology: Perspectives from Molecular Biology
Journal:
Current Drug Targets
Volume:
2
Page:
215-231
Author(s):
David R. Lynch and Rodney P. Guttmann
Neuroprotection by NMDA Receptor Antagonists in a Variety of Neuropathologies
Journal:
Current Drug Targets
Volume:
2
Page:
241-271
Author(s):
Gene C. Palmer
Ifenprodil, a Novel NMDA Receptor Antagonist : Site and Mechanism of Action
Journal:
Current Drug Targets
Volume:
2
Page:
285-298
Author(s):
Keith Williams
Activators and Inhibitors of the Ion Channel of the NMDA Receptor
Journal:
Current Drug Targets
Volume:
2
Page:
323-329
Author(s):
Rebecca C. Klein and Francis J. Castellino
The Use of Antibody Engineering to Create Novel Drugs that Target N-methyl-D-Aspartate Receptors
Journal:
Current Drug Targets
Volume:
2
Page:
331-345
Author(s):
Joseph R. Moskal, Hirotaka Yamamoto and Patricia A. Colley
synthesis and Structure-Activity Relationships of 2,3-Benzodiazepines as AMPA Receptor Antagonists
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
1
Page:
243-253
Author(s):
M. Zappala, S. Grasso, N. Micale, S. Polimeni and C. De Micheli